Participants 88 133 5
newly diagnosed stage 1 hypertensive patients
Participants 678 757 7
60 newly diagnosed stage 1 hypertensive patients with no other systemic disease
Participants 799 813 3
nebivolol 5 mg
Participants 875 893 3
nd valsartan 160 m
